Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia

Clinical trial NCT06338839 · TERMINATED

Trial details

NCT number: NCT06338839
Sponsor: AstraZeneca
Status: TERMINATED
Study type: OBSERVATIONAL

Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction

Start date: 2023-12-28
Primary completion: 2024-06-25
Enrollment: 1770

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.